BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25030834)

  • 1. Diagnostic value of circulating microRNAs for hepatocellular carcinoma.
    Yang Y; Zhu R
    Mol Biol Rep; 2014 Oct; 41(10):6919-29. PubMed ID: 25030834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis.
    Yin H; Peng X; Ren P; Cheng B; Li S; Qin C
    Tumour Biol; 2014 Dec; 35(12):12317-26. PubMed ID: 25204672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis.
    Jiang Y; He J; Li Y; Guo Y; Tao H
    Biomed Res Int; 2019; 2019():5179048. PubMed ID: 31871941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis.
    Liao Q; Han P; Huang Y; Wu Z; Chen Q; Li S; Ye J; Wu X
    PLoS One; 2015; 10(6):e0130677. PubMed ID: 26114756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
    Li G; Shen Q; Li C; Li D; Chen J; He M
    Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis.
    Huang Y; Chen Y; Tu S; Zhang J; Qiu Y; Yu W
    BMC Infect Dis; 2022 Apr; 22(1):323. PubMed ID: 35365115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
    Zhao XF; Li N; Lin DD; Sun LB
    Biomed Res Int; 2020; 2020():5353695. PubMed ID: 32309434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data.
    Zhang WT; Gil-Gómez A; Liu CH; Gao SS; Romero-Gómez M
    Rev Esp Enferm Dig; 2022 May; 114(5):280-288. PubMed ID: 34423645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of lncRNAs as Biomarker in Hepatocellular Carcinoma: An Updated Meta-Analysis.
    Chen S; Zhang Y; Wu X; Zhang C; Li G
    Can J Gastroenterol Hepatol; 2018; 2018():8410195. PubMed ID: 30410873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-223 in gastrointestinal cancers: A systematic review and diagnostic meta-analysis.
    Aalami AH; Abdeahad H; Mesgari M; Sahebkar A
    Eur J Clin Invest; 2021 Feb; 51(2):e13448. PubMed ID: 33244751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
    Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
    Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Ras association domain family 1A promoter methylation and hepatocellular carcinoma: a meta-analysis.
    Zhao ZH; Fan YC; Yang Y; Wang K
    World J Gastroenterol; 2013 Nov; 19(41):7189-96. PubMed ID: 24222965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
    Jiang L; Cheng Q; Zhang BH; Zhang MZ
    Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNAs as biomarkers for the diagnosis of hepatocellular carcinoma: A meta-analysis.
    Zeng C; Tang Y; Jiang Y; Zuo Z; Tao H
    Pathol Res Pract; 2021 Aug; 224():153546. PubMed ID: 34332221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive power of circulating miRNAs in detecting colorectal cancer.
    Zeng W; Tu Y; Zhu Y; Wang Z; Li C; Lao L; Wu G
    Tumour Biol; 2015 Apr; 36(4):2559-67. PubMed ID: 25527153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the value of miR-21 in the diagnosis of early stage HCC and its prognosis: a meta-analysis.
    Yan SR; Liu ZJ; Yu S; Bao YX
    Genet Mol Res; 2015 Sep; 14(3):11573-86. PubMed ID: 26436398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Fecal MicroRNAs for Colorectal Cancer: a Meta-Analysis.
    Wang C; Zhao K; Rong Q
    Clin Lab; 2015; 61(12):1845-53. PubMed ID: 26882806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma.
    Huang JT; Liu SM; Ma H; Yang Y; Zhang X; Sun H; Zhang X; Xu J; Wang J
    J Cell Physiol; 2016 Feb; 231(2):328-35. PubMed ID: 26291451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
    Liu L; Wang S; Cao X; Liu J
    Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of circulating microRNAs for lung cancer: a meta-analysis.
    Shen Y; Wang T; Yang T; Hu Q; Wan C; Chen L; Wen F
    Genet Test Mol Biomarkers; 2013 May; 17(5):359-66. PubMed ID: 23387316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.